Stuart Cain

Vice President of Business Development, Bowen's FX Therapeutics

Dr. Stuart Cain is a Scientist Mentor in the CDL Global – Advanced Therapies Stream, with experience ranging from academic research into neurological disorders to drug development in the biotechnology sector. Currently, he is VP of Business Development for Bowen’s FX Therapeutics, a biotech company developing a biologic therapy for Fragile X syndrome. Previously, he worked in the Program Development and Partnerships team at adMare BioInnovations where his role included identifying, evaluating, development planning and executing high-value drug development programs. He has been actively involved in several CDL Health-related streams since 2020. Dr. Cain holds an BSc (Hons) degree in pharmacology, and a PhD in neurophysiology / neuropharmacology.